Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C9H24N2O.2I |
| Molecular Weight | 430.1086 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[I-].[I-].C[N+](C)(C)CC(O)C[N+](C)(C)C
InChI
InChIKey=UOZDOLIXBYLRAC-UHFFFAOYSA-L
InChI=1S/C9H24N2O.2HI/c1-10(2,3)7-9(12)8-11(4,5)6;;/h9,12H,7-8H2,1-6H3;2*1H/q+2;;/p-2
| Molecular Formula | HI |
| Molecular Weight | 127.91241 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C9H23N2O |
| Molecular Weight | 175.2917 |
| Charge | 1 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Prolonium is a quartenary amine derivative. Prolonium iodide has been given by injection as a source of iodine as part of the treatment of thyroid storm and for the pre-operative management of hyperthyroidism. It is marketed in Italy for veterinary use for the treatment of infectious granulomas, in the various forms of actinomycosis actinobacillosis of the tongue, larynx, pharynx, skin and subcutaneous connective tissue.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:35 GMT 2025
by
admin
on
Mon Mar 31 18:33:35 GMT 2025
|
| Record UNII |
VKH95UNQ6N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1550
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
VKH95UNQ6N
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
m9167
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | Merck Index | ||
|
SUB10084MIG
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
C036108
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
DTXSID201021784
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
204-630-9
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
C1505
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
CONCEPT | Dietary Supplement | ||
|
100000081125
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
C74336
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
123-47-7
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
4149
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
67158
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY | |||
|
CHEMBL1180550
Created by
admin on Mon Mar 31 18:33:35 GMT 2025 , Edited by admin on Mon Mar 31 18:33:35 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
